Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Hematologic Neoplasms × Nivolumab × Clear all

Phase

Status

Terminated 4 Completed 4 Withdrawn 2 Unknown 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Melanoma 22 Carcinoma, Non-Small-Cell Lung 22 Stomach Neoplasms 8 Neoplasms 6 Carcinoma, Renal Cell 6 Carcinoma, Hepatocellular 6 Breast Neoplasms 5 Triple Negative Breast Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 4 Neoplasm Metastasis 4 Hodgkin Disease 4 Urinary Bladder Neoplasms 3 Prostatic Neoplasms 3 Pancreatic Neoplasms 3 Lung Neoplasms 3 Head and Neck Neoplasms 3 Uveal Melanoma 2 Small Cell Lung Carcinoma 2 Sarcoma 2 Mesothelioma, Malignant 2 Lymphoma, B-Cell 2 Gastrointestinal Neoplasms 2 Esophageal Squamous Cell Carcinoma 2 Esophageal Neoplasms 2 Carcinoma, Transitional Cell 2 Carcinoma, Merkel Cell 2 Brain Neoplasms 2 Uterine Cervical Neoplasms 1 Urogenital Neoplasms 1 Thymoma 1

Interventions

Cyclophosphamide 6 fludarabine 4 Immunotherapy, Adoptive 3 Exercise 3 Blood Specimen Collection 3 Surveys and Questionnaires 2 Stem Cell Transplantation 2 Physical Therapy Modalities 2 Parenteral Nutrition 2 CF regimen 2 BNT162 Vaccine 2 trihexyltetradecylphosphonium chloride 1 treosulfan 1 thymoglobulin 1 shengxuening 1 ruxolitinib 1 ramosetron 1 pegylated granulocyte colony-stimulating factor 1 monalizumab 1 glucarpidase 1 fludarabine phosphate 1 ferrous succinate 1 eltrombopag 1 dexamethasone 21-phosphate 1 Whole-Body Irradiation 1 Voriconazole 1 Vaccination 1 Tropisetron 1 Tretinoin 1 Transplantation 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03146468 2021-09-23

NIVALLO

Melbourne Health

Phase 2 Unknown

Other hematologic neoplasm

Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡